Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-25T08:18:21.765Z Has data issue: false hasContentIssue false

VENLAFAXINE

Published online by Cambridge University Press:  03 April 2024

Stephen M. Stahl
Affiliation:
University of California, San Diego and Riverside
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Prescriber's Guide
Stahl's Essential Psychopharmacology
, pp. 873 - 878
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

Buckley, NA, McManus, PR. Fatal toxicity of serotonergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002;325:1332–3.CrossRefGoogle Scholar
Cheeta, S, Schifano, F, Oyefeso, A, Webb, L, Ghodse, AH. Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000. Br J Psychiatry 2004;184:41–7.CrossRefGoogle ScholarPubMed
Davidson, J, Watkins, L, Owens, M, et al. Effects of paroxetine and venlafaxine XR on heart rate variability in depression. J Clin Psychopharmacol 2005;25:4804.CrossRefGoogle ScholarPubMed
Hackett, D. Venlafaxine XR in the treatment of anxiety. Acta Psychiatrica Scand 2000;406(Suppl):S30–5.CrossRefGoogle Scholar
Sheehan, DV. Attaining remission in generalized anxiety disorder: venlafaxine extended-release comparative data. J Clin Psychiatry 2001;62(Suppl 19):S26–31.Google ScholarPubMed
Smith, D, Dempster, C, Glanville, J, Freemantle, N, Anderson, I. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry 2002;180:396–404.CrossRefGoogle ScholarPubMed
Wellington, K, Perry, CM. Venlafaxine extended-release: a review of its use in the management of major depression. CNS Drugs 2001;15:6439.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • VENLAFAXINE
  • Stephen M. Stahl, University of California, San Diego and Riverside
  • Book: Prescriber's Guide
  • Online publication: 03 April 2024
  • Chapter DOI: https://doi.org/10.1017/9781009464772.148
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • VENLAFAXINE
  • Stephen M. Stahl, University of California, San Diego and Riverside
  • Book: Prescriber's Guide
  • Online publication: 03 April 2024
  • Chapter DOI: https://doi.org/10.1017/9781009464772.148
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • VENLAFAXINE
  • Stephen M. Stahl, University of California, San Diego and Riverside
  • Book: Prescriber's Guide
  • Online publication: 03 April 2024
  • Chapter DOI: https://doi.org/10.1017/9781009464772.148
Available formats
×